mRNA
Symposium on mRNA Therapy Products: Manufacturing, Quality, and Regulatory Considerations
In the span of just two decades, messenger RNAs (mRNAs) have gone from biological proof-of-concept to an essential and growing class of therapeutics. The discovery of nucleoside modifications which bypassed the inflammatory response opened the door to mRNAs as a new modality, its possibilities best exemplified by the remarkable development and global adoption of mRNA vaccines against COVID-19. Today, sponsors are developing mRNA vaccines against a wide array of infectious diseases, and many are exploring the application of mRNA agents for indications such as cystic fibrosis, metabolic diseases, and cancer. Advancements in nucleic acid delivery and in vivo gene editing hold the potential to even further broaden the therapeutic applications of mRNA. The NEW Symposium on mRNA will explore how mRNA has become a new modality, how mRNA vaccines are applied against a wide array of infectious diseases, and how many are exploring the application of mRNA agents for other diseases.
Save the Date
Mark your calendars for the NEW Symposium on mRNA on May 29-30, 2025 in Gaithersburg, MD. Registration will open in February.
CASSS On Demand
Access approved content from past meetings in the CASSS On Demand platform. CASSS members have access to all available presentation recordings. Visit ondemand.casss.org,
login to your account, and select from the list of meetings to begin.
Review Resources
Want to revisit a keynote presentation? Missed important details that may impact your work?
Visit Papers and Presentations to access relevant presentations, summary papers, and roundtable notes.